Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 37.28
+0.37 (1.00%)
Jan 20, 2026, 4:00 PM EST
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 3.33 billion as of January 23, 2026. Its market cap has increased by 50.56% in one year.
Market Cap
3.33B
Enterprise Value
1.99B
Revenue
439.57M
Ranking
n/a
PE Ratio
44.11
Stock Price
37.28
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 3.33B, a decrease of -45.47%. That is a compound annual growth rate of -14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.33B | 14.09% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yantai Zhenghai Biotechnology | 3.89B |
| Beijing Kawin Technology Share-Holding | 3.86B |
| Baolingbao Biology | 3.85B |
| Shanghai Model Organisms Center | 3.71B |
| Novoprotein Scientific | 3.49B |
| Guangdong VTR Bio-Tech | 3.42B |
| Cabio Biotech (Wuhan) | 3.39B |
| Jiangsu CoWin Biotech | 3.06B |